Matt Kuntz

Matt Kuntz is a seasoned regulatory affairs executive with over two decades of experience in the pharmaceutical industry, currently serving as Vice President of Global Regulatory Affairs for Neuroscience at AbbVie since September 2012. In this role, Matt develops and implements global regulatory strategies for neuroscience products, acting as a key regulatory voice in cross-functional teams to navigate the approval process. Prior to AbbVie, Matt held various leadership positions at Eli Lilly and Company, overseeing global regulatory strategies and compliance initiatives across therapeutic areas, while also establishing critical partnerships with drug development teams. Matt Kuntz holds a BS in Pharmacy from Purdue University, a PharmD from the University of Florida, and an MBA from the Indiana University Kelley School of Business.